T
Toku Eyes develops AI-driven diagnostic tools that analyze retinal images to assess biological age, cardiovascular risk, and chronic kidney disease. By enabling early detection of health issues through routine eye exams, the company aims to improve patient outcomes and alleviate pressure on healthcare systems.
Updated 4 months ago
Funding
$2.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Toku Eyes develops AI-driven diagnostic tools that analyze retinal images to assess biological age, cardiovascular risk, and chronic kidney disease. By enabling early detection of health issues through routine eye exams, the company aims to improve patient outcomes and alleviate pressure on healthcare systems.